The effect of platelet-rich plasma on pain, function, and quality of life of patients with knee osteoarthritis

Seyed Ahmad Raeissadat, Seyed Mansoor Rayegani, Marzieh Babaee, Elham Ghorbani, Seyed Ahmad Raeissadat, Seyed Mansoor Rayegani, Marzieh Babaee, Elham Ghorbani

Abstract

Background. New studies in the management of knee osteoarthritis have focused on modern therapeutic methods stimulating cartilage healing process. In the present study, we evaluated the effects of 2 courses of leucocyte-rich PRP (LR-PRP) injections on patients' QOL and functions and also the relationship between the PRP concentration and mentioned variables. Material and Methods. Sixty-five patients were evaluated. For each participant, WOMAC and the native (Farsi) edition of the SF-36 questionnaire were filled. Two courses of LR-PRP injections with 4-week interval were used. After 6 months, SF-36 and WOMAC questionnaires were filled again for each patient. Results. 60 patients were included in the final analysis. The mean platelet concentrations and white blood cell in PRP was 5-fold increase and 220 per microliter, respectively. The mean total WOMAC revealed significant change (P = 0.001). In SF-36, the mean changes of 2 major physical and mental domains were meaningful (P = 0.001). Discussion. In our study, 2 injections of PRP, with 4-week interval, improved the pain, stiffness, and functional capacity. Improvements in QOL (both PCS and MCS) were meaningful after injections. These changes were more significant in physical domains. PRP injection may be an alternative therapy in selective patients resistant to current nonsurgical treatments of knee osteoarthritis.

Figures

Figure 1
Figure 1
WOMAC index: pre- and posttreatment marks for pain, stiffness, and functional capacity. All results show significant improvement (P = 0.001).
Figure 2
Figure 2
SF-36 test: pre- and posttreatment for the mental health domain and physical health domain. *These components were statistically significant.

References

    1. Wang-Saegusa A, Cugat R, Ares O, Seijas R, Cuscó X, Garcia-Balletbó M. Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life. Archives of Orthopaedic and Trauma Surgery. 2011;131(3):311–317.
    1. Crane D, Everts P. Platelet rich plasma (PRP) matrix grafts. Pract Pain Manage. 2008;8:12–26.
    1. Filardo G, Kon E, Buda R, et al. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surgery, Sports Traumatology, Arthroscopy. 2011;19(4):528–535.
    1. Kon E, Buda R, Filardo G, et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surgery, Sports Traumatology, Arthroscopy. 2010;18(4):472–479.
    1. Sampson S, Gerhardt M, Mandelbaum B. Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Ethics in Science and Environmental Politics. 2008;1(3):165–174.
    1. Tate K, Crane D. Platelet rich plasma grafts in musculoskeletal medicine. Journal of Prolotherapy. 2010;2(2):371–376.
    1. Mishra A, Woodall J, Jr., Vieira A. Treatment of tendon and muscle using platelet-rich plasma. Clinics in Sports Medicine. 2009;28(1):113–125.
    1. Rabago D, Best TM, Zgierska AE, Zeisig E, Ryan M, Crane D. A systematic review of four injection therapies for lateral epicondylosis: prolotherapy, polidocanol, whole blood and platelet-rich plasma. British Journal of Sports Medicine. 2009;43(7):471–481.
    1. Bir SC, Esaki J, Marui A, et al. Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the ischemic hind limb of the mouse. Journal of Vascular Surgery. 2009;50(4):870–879.e2.
    1. Smyth NA, Murawski CD, Fortier LA, Cole BJ, Kennedy JG. Platelet-rich plasma in the pathologic processes of cartilage: review of basic science evidence. Arthroscopy. 2013;29(8):1399–1409.
    1. Hall MP, Band PA, Meislin RT, Jazrawi LM, Cardone DA. Platelet-rich plasma: current concepts and application in sports medicine. Journal of the American Academy of Orthopaedic Surgeons. 2009;17(10):602–608.
    1. McPherson RA, Pincus MR. Henry's Clinical diagnosis and Management by Laboratory methodS. Elsevier Health Sciences; 2011.
    1. De La Mata J. Platelet rich plasma. A new treatment tool for the rheumatologist? Reumatologia Clinica. 2012
    1. De Vos RJ, Van Veldhoven PLJ, Moen MH, Weir A, Tol JL, Maffulli N. Autologous growth factor injections in chronic tendinopathy: a systematic review. British Medical Bulletin. 2010;95(1):63–77.
    1. Kim SR, Stitik TP, Foye PM, Greenwald BD, Campagnolo DI. Critical review of prolotherapy for osteoarthritis, low back pain and other musculoskeletal conditions: a physiatric perspective. American Journal of Physical Medicine & Rehabilitation. 2004;83(5):379–389.
    1. Emel E, Ergün SS, Kotan D, et al. Effects of insulin-like growth factor-I and platelet-rich plasma on sciatic nerve crush injury in a rat model: laboratory investigation. Journal of Neurosurgery. 2011;114(2):522–528.
    1. Wehberg KE, Answini G, Wood D, et al. Intramyocardial injection of autologous platelet-rich plasma combined with transmyocardial revascularization. Cell Transplantation. 2009;18(3):353–359.
    1. Spaková T, Rosocha J, Lacko M, Harvanová D, Gharaibeh A. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. American Journal of Physical Medicine & Rehabilitation. 2012;91(5):411–417.
    1. Sánchez M, Fiz N, Azofra J, et al. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy. 2012;28(8):1070–1078.
    1. Park YG, Han SB, Song SJ, Kim TJ, Ha CW. Platelet-rich plasma therapy for knee joint problems: review of the literature, current practice and legal perspectives in Korea. Knee Surgery & Related Research. 2012;24(2):70–78.
    1. Frizziero A, Giannotti E, Ferraro C, Masiero S. Platelet rich plasma intra-articular injections: a new therapeutic strategy for the treatment of knee osteoarthritis in sport rehabilitation. A systematic review. Sport Sciences for Health. 2012;8(1):15–22.
    1. Li M, Zhang C, Ai Z, Yuan T, Feng Y, Jia W. Therapeutic effectiveness of intra-knee-articular injection of platelet-rich plasma on knee articular cartilage degeneration. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2011;25(10):1192–1196.
    1. Sampson S, Reed M, Silvers H, Meng M, Mandelbaum B. Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study. American Journal of Physical Medicine & Rehabilitation. 2010;89(12):961–969.
    1. Zhu Y, Yuan M, Meng HY, et al. Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review. Osteoarthritis Cartilage. 2013;21(11):1627–1637.
    1. Kijowski R, Blankenbaker D, Stanton P, Fine J, De Smet A. Arthroscopic validation of radiographic grading scales of osteoarthritis of the tibiofemoral joint. American Journal of Roentgenology. 2006;187(3):794–799.
    1. Hochberg MC. Proposed 2011 American College of Rheumatology recommendations for the use of non-pharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip and knee. Seminars in Arthritis and Rheumatism. 2012;41(1):92–93.
    1. Misso ML, Pitt VJ, Jones KM, Barnes HN, Piterman L, Green SE. Quality and consistency of clinical practice guidelines for diagnosis and management of osteoarthritis of the hip and knee: a descriptive overview of published guidelines. Medical Journal of Australia. 2008;189(7):394–399.
    1. Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. The short form health survey (SF-36): translation and validation study of the Iranian version. Quality of Life Research. 2005;14(3):875–882.
    1. McConnell S, Kolopack P, Davis AM. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. Arthritis Care and Research. 2001;45(5):453–461.
    1. Kon E, Mandelbaum B, Buda R, et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy. 2011;27(11):1490–1501.
    1. Filardo G, Kon E, Di Martino A, et al. Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskeletal Disorders. 2012;13(1):p. 229.
    1. Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. The American Journal of Sports Medicine. 2013;41(2):356–364.
    1. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dentistry. 2001;10(4):225–228.
    1. Gobbi A, Karnatzikos G, Mahajan V, Malchira S. Platelet-rich plasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients. Sports Health. 2012;4(2):162–172.
    1. Napolitano M, Matera S, Bossio M, et al. Autologous platelet gel for tissue regeneration in degenerative disorders of the knee. Blood Transfusion. 2012;10(1):72–77.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever